ArticleCoordination chemistry reviews2025
Application of smart responsive nanomaterials in the theranostics of gastrointestinal malignancies: Current status and future perspectives.
Article in Coordination chemistry reviews, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
6 citing papers in PubMed.
- Ligand decorated nanostructure carrier systems for targeted delivery of antimalarials.Discover nano · 2026Review
- Highly transparent, stretchable and flexible SERS sensor for rapid and in-situ detection of malachite green in aquaculture.Mikrochimica acta · 2026Article
- Aptamer-modified metal-organic framework fiber network as a selective and recyclable affinity pretreatment column for aflatoxin B1 enrichment in feed.Mikrochimica acta · 2026Article
- Applications of Nanobiotechnology in Medicine.Life (Basel, Switzerland) · 2026Review
- The Gastrointestinal Tract: A Unique Battlefield for Bioengineering Delivery Platforms.Bioengineering (Basel, Switzerland) · 2025Review
- Smartphone electrochemical sensor based on laser-induced graphene integrated electrode for on-site sulfadimidine detection in beef and milk.Mikrochimica acta · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
Gastrointestinal (GI) malignancies remain to be one of the most prevalent malignancies that are often characterized by a dismal prognosis. Nanoplatforms present a groundbreaking avenue for enhancing targeting strategies and multifunctionality in cancer treatment. The emergence of nanotechnology, particularly the innovation of smart responsive nanomaterials, has revolutionized cancer diagnosis and therapy. This review begins by exploring the design principles of smart responsive nanomaterials, focusing on the various exogenous and endogenous stimuli that drive their functionality. Furthermore, we provide a comprehensive summary of the applications of smart responsive nanomaterials in the treatment of GI malignancies over the past five years. Our aim is to contribute to the growing body of knowledge on smart responsive nanomaterials in GI malignancies, spark innovative ideas, and encourage further advancements in this field. Finally, we discuss the prospects and challenges associated with the use of smart responsive nanomaterials in GI malignancies.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.